In the PD-L1-KLN205 tumor-bearing mice, the effects of PDI-1 on peripheral blood T cells were more variable than in hPD-L1-B16-F10-bearing mice, although the percentage of CD8+ cells was significantly higher in PDI-1-treated mice than in vehicle-treated mice (Figure 6C). This evidence concerns the gene CD8A and neoplasm.